Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPACH and NQABC Recipes for Acute Ischemic Stroke
NCT04199455Phase 4Unknown
- Sponsor
- Guangzhou University of Chinese Medicine
- Start
- Dec 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of etoposide + prednisone + doxorubicin + cyclophosphamide + altretamine in ischemic stroke, sponsored by Guangzhou University of Chinese Medicine. Status: unknown.
02
Drugs
etoposide + prednisone + doxorubicin + cyclophosphamide + altretamine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04199455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04199455.